| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |